Medicare

5 articles

Trump administration plan could weaken Medicare drug price negotiation

In 2024, Medicare spent $125 billion on just 40 drugs, representing over one-third (36%) of its total drug budget, according to KFF .

Marcus Cole·June 13, 2026

Scientist in a futuristic lab analyzing a GLP-1 drug vial with holographic displays showing molecular structures and patient data.

Cosmos & Space

Medicare offers $50 monthly GLP-1 access amid obesity drug competition

Starting July 1, 2026, eligible Medicare beneficiaries will pay just $50 a month for certain GLP-1 obesity drugs.

Marcus Cole·June 8, 2026

Eligible Medicare beneficiaries smiling as they receive prescription for weight-loss medication, symbolizing improved access and affordability.

Cosmos & Space

Medicare Unveils $50 Monthly Cap on Obesity Drugs

Starting in July, eligible Medicare beneficiaries will access GLP-1 weight-loss medications for a monthly cost of just $50, according to The Motley Fool .

Aram Sarkisian·June 1, 2026

Split image comparing Trump administration drug pricing deals with the complex negotiation process of the Inflation Reduction Act, highlighting the test of new drug launches.

Health & Medicine

Trump Drug Pricing Deals Face Test as New Drugs Launch

The Medicare negotiated price for semaglutide, the active ingredient in blockbuster drugs like Ozempic, is $274 under the Inflation Reduction Act.

Marcus Cole·May 28, 2026

Elderly people receiving long-term care at home, in the community, and in nursing facilities, highlighting the proposed Medicare benefit.

Health & Medicine

Senate Democrats propose Medicare long-term care benefit

With the average annual cost of a nursing home exceeding $93,000 and Medicare covering almost none of it, Senate Democrats today proposed a new long-term care benefit, funded by a new payroll tax.

Aram Sarkisian·May 20, 2026